Germany

News from aidsmap

• T-20 expanded access study announced

  Anna Poppa | 07 November 2001

  Roche have announced plans for widening access to their experimental fusion inhibitor, T-20 (pentafuside), a new type of anti-HIV treatment. A worldwide open-label safety study, codenamed T-20 305, is ...

• Syphilis in HIV-positive gay Hamburgers

  Robert Fieldhouse | 30 October 2001

  One hundred years ago the German philosopher Friedrich Nietzsche lost his mental faculties as a result of tertiary syphilis infection. Today in the UK it is rare that the disease advances ...

• Treating high cholesterol in HAART patients

  Keith Alcorn | 29 October 2001

  Controversy over the risk of heart disease in people on HAART continued at the Third International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV Infection last week, with competing ...

• Treatment of early hepatitis C prevents disease progression

  Robert Fieldhouse | 16 October 2001

  Researchers from the Medizinische Hochschule in Hannover, Germany in association with the clinic of infective diseases at the University of Bari, Italy have shown that treatment of acute hepatitis C ...

• More tricky drug interactions: fine tuning HAART

  Keith Alcorn | 05 March 2001

  Highlights from the First International Workshop on Clinical Pharmacology of HIV Therapy, Noordwijk, The Netherlands, March 30-31, 2000. Using efavirenz with bid IDV/RTV 800/100mg ABT-378/r with other PIs Amprenavir and ritonavir Amprenavir/ritonavir and efavirenz Saquinavir ...

• US signals need for shorter salvage trials - but still out of step with Europe

  Keith Alcorn | 05 March 2001

  The US Food and Drug Administration has signalled that it is willing to move in the direction of shorter trials to license drugs for salvage therapy, following the lead of ...

• Delavirdine setback in Europe

  Anon | 05 March 2001

  Pharmacia & Upjohn has been given the thumbs down for its NNRTI delavirdine (Rescriptor ,TM) by the CPMP, the scientific advisory committee of the European Medicines Evaluation Agency (EMEA). This ...

• South African judge slams pharma cos in conference keynote speech

  Keith Alcorn | 05 March 2001

  Justice Edwin Cameron of South Africa’s High Court launched a blistering attack on pharmaceutical companies and his country’s government in a keynote address to the Thirteenth World AIDS Conference today ...